Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer()

BACKGROUND: Immunotherapy using dendritic cell (DC) vaccine has the potential to overcome the bottleneck of cancer therapy. METHODS: We engineered Lewis lung cancer cells (LLCs) and bone marrow–derived DCs to express tumor-associated antigen (TAA) ovalbumin (OVA) via lentiviral vector plasmid encodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tao, Chen, Xiao, Zhou, Wei, Fan, Guoxin, Zhao, Peilin, Ren, Shengxiang, Zhou, Caicun, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266489/
https://www.ncbi.nlm.nih.gov/pubmed/28129580
http://dx.doi.org/10.1016/j.tranon.2016.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266489/
https://www.ncbi.nlm.nih.gov/pubmed/28129580
http://dx.doi.org/10.1016/j.tranon.2016.12.002

Ejemplares similares